First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome

Main Article Content

B. Palterer
G. Vitiello *
D. Cammelli
(*) Corresponding Author:
G. Vitiello | gianfranco.vitiello@unifi.it

Abstract

Inflammatory myopathies as para-neoplastic phenomena were first described by Sterz in 1916. Recently, myositis specific autoantibodies were described in cancer-associated myositis. Anti-transcription intermediary factor 1 gamma (anti-TIF1γ) antibodies have been found in both young adults affected by juvenile dermatomyositis and in elderly patients with cancer-associated myositis. In this regard, we report herein the first case of anti-TIF1γ dermatomyositis secondary to a myelodysplastic syndrome.

Downloads month by month

Downloads

Download data is not yet available.

Article Details

Author Biographies

B. Palterer, Experimental and Clinical Medicine Dept., University of Florence, Florence

Resident in Allergy and Clinical Immunology

G. Vitiello, Experimental and Clinical Medicine Dept., University of Florence, Florence

Resident in Allergy and Clinical Immunology

D. Cammelli, Rheumatology Section/Immunoallergology Unit, AOU-Careggi, Florence

Head of the Reumatology Section of the Immunoallergology Unit